var data={"title":"Society guideline links: Lipid disorders in adults","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Society guideline links: Lipid disorders in adults</div><p class=\"disclosureLink\"></p><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H2667277866\"><span class=\"h1\">Introduction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.</p><p>The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.</p><p>Links to related guidelines are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-lipid-disorders-and-atherosclerosis-in-children\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Lipid disorders and atherosclerosis in children&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-obesity-in-adults\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Obesity in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H559281906\"><span class=\"h1\">Canada</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.onlinecjc.ca/article/S0828-282X(16)30732-2/pdf&amp;token=sdhIPDOeK9pJPGhyi0+CjVxbTA/Y7jX73PW0DCIkomCtxSMbL9GPxdUYfCyTw3o/cGZXNqQe6UfTZcL9sY2rhzutylEG8HayQrvuaAu0spA=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Canadian Cardiovascular Society (CCS): Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.onlinecjc.ca/article/S0828-282X(14)01443-3/pdf&amp;token=sdhIPDOeK9pJPGhyi0+CjVxbTA/Y7jX73PW0DCIkomDmOBW3RtwO+Hevg7x3nD3dbsTki/AHZmCPupgNZ+XJUzIS7xkyqdUwKY0E1DDtGMk=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">CCS: Position statement on familial hypercholesterolemia</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://press.endocrine.org/doi/full/10.1210/jc.2011-3213&amp;token=lQf0wpS2mWdQkv9aeyFMecir9mKJ4fjTFJmHJqsQ5gj4a0ryVaZq6z1ku5GKoHud6RFE+awqGGpF63URuPAUMA==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Endocrine Society (ES): Clinical practice guideline on evaluation and treatment of hypertriglyceridemia</a> (2013)</p><p/><p class=\"headingAnchor\" id=\"H3701421603\"><span class=\"h1\">United States</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.aace.com/files/lipid-guidelines.pdf&amp;token=Zhk3SsDNzGEOSDTcBVv9fWBgqaWK71vv+tLI83PiKL1oBxIoU5/XgRU9x0neeOVm4Vsmul1LKqQKvq0OgSos5w==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE): Guidelines for management of dyslipidemia and prevention of cardiovascular disease</a> (2017)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://ac.els-cdn.com/S0735109716323981/1-s2.0-S0735109716323981-main.pdf?_tid=8366fbc0-6c95-11e7-823b-00000aab0f26&acdnat=1500477687_ae48bc0c8b4cca1b1e49b2e4397ca942&amp;token=TzDyNGCA7uX+TX+8fYJ3E2RH/Kcd27re86VAIT4VbvdBBBJdsLFjQJjlCYCAahRiMijZcSyGW/jYItJ9ZakJ7SRaD1XetfS7buvRUKUprVKWC1QbOeGwWik/U4QiXehLNiH+O9pFDwtFxyXySfWsHr+TDT6cgJeC7DOE69Z8lsNOcS1sPfJksVrAU0/hGIzX&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">American College of Cardiology (ACC): Expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/early/2016/10/31/CIR.0000000000000450&amp;token=00inXdwsnxmDElcuPW2z2LjblLtNuarJCrgTvRJecCZLuo/vQRNxZMpcWeYcz1Aw9wopNJJjsHhwbcWcCfHsTeaLOUAQZU8uhXMCEQJIw/Y=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">American Heart Association (AHA): Scientific statement on contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/american-society-clinical-pathology-expanded-lipid-panels-to-screen-for-cardiovascular-disease/&amp;token=t3Zn3A80oeCFuRuqXtoqDDVX4aG0LOirCSN0Fj7qeQAt4Xtcc1EcoSjH/Z17d9vXnC+7ZnamSvt1iA8KttRBymnOjPPy4i+bIqfdYjB6GN+BNKkrKdgxiUS+fp/NWUBo3rYRy2eLRf39KFwUopC5Yw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Choosing Wisely: Do not routinely order expanded lipid panels (particle sizing, nuclear magnetic resonance) as screening tests for cardiovascular disease</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lipid-disorders-in-children-screening1&amp;token=bXM9hqqLIkiHailMu3NRFJ9XIttaRMB2h8t5/anXgzUkvT+HxiChQgqeYmeM0WRsEzmnQ3oPkyv9y7Dx2V8a61ZB38AhXj7T+ZBPQh0NaMuQ2j5m1dVQlA2CWDsdOSE4W3AUJJPPKa/lgNx4v7ivcw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">US Preventive Services Task Force (USPSTF): Final recommendation statement on lipid disorders in children and adolescents &ndash; Screening</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication1&amp;token=2fDdGK4H8A4ALxvsqtz2Hc8Skx+RsHa4qGpa9GnzLybqVP7XPMEDA+ihBmcyeKg/9dPleY/Y0jG6vTUhXh1BBHYH8OtqENdXVoqVZtIMeNsFkFfmg7noxImWym+UHsiwdWwmkZgt7KRDsoE0/Maprw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">USPSTF: Final recommendation statement on statin use for the primary prevention of cardiovascular disease in adults &ndash; Preventive medication</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/132/22/2167&amp;token=00inXdwsnxmDElcuPW2z2LjblLtNuarJCrgTvRJecCY0Gi2WZlSf5Bv2xckdSjoIZBYrw5g4oZOIKO5QvyjDXw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">AHA: Scientific statement on the agenda for familial hypercholesterolemia</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.lipidjournal.com/article/S1933-2874(15)00059-8/abstract&amp;token=2zSk/UZTeO3J4oIM4h1Di3cRdUk4ItAx6TcU10we/lC1wHHqCw7+aQEgDvgGWWF/928TGtHQ3H6QUhi5e1VKHtkstXkxIBm883mLtOosUNc=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">National Lipid Association (NLA): Recommendations for patient-centered management of dyslipidemia &ndash; Part 1</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.lipidjournal.com/article/S1933-2874(15)00380-3/abstract&amp;token=2zSk/UZTeO3J4oIM4h1Di3cRdUk4ItAx6TcU10we/lC1wHHqCw7+aQEgDvgGWWF/WrBP0A5S4eT/1eiShnpLEH5P9l95aD0ywSMbifFNTtQ=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">NLA: Recommendations for patient-centered management of dyslipidemia &ndash; Part 2</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://stroke.ahajournals.org/content/45/7/2160.full.pdf+html&amp;token=PzC1FvLU7NonTzssRKEPELQ9g60XttHCa6za1Nl+aTMSr2hZrnvK2ZF0+S3dfSVVRcX94JfXGQzFlyH+ldUUD3AHQPOYaEtgnD6WIvI/oEs=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">AHA/American Stroke Association (ASA): Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.healthquality.va.gov/guidelines/CD/lipids/&amp;token=rvTukyyIVowC5RKz8kYMi33ESf7wg/DJYFm7Qim9QPai6i7/a8c1V5lXLSJsbpUV4IOcHlrWprWjqhfZrH/fVQ==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">US Department of Veterans Affairs (VA) and US Department of Defense (DoD): Clinical practice guideline on management of dyslipidemia for cardiovascular disease risk reduction</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437740.48606.d1&amp;token=KR93jQSf/9vw2AATNPmu/qN/+MHHBQpk42HTabDEeeYNCAwn9ihgRo6XnA6OZ/E7fGegHPXLidLndUcuAvgEukbvNcm2gy04FXDZWO3eDik=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">ACC/AHA: Guideline on lifestyle management to reduce cardiovascular risk</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/129/25_suppl_2/S49&amp;token=00inXdwsnxmDElcuPW2z2LjblLtNuarJCrgTvRJecCZqP1kwQee91O8Deo5RDM6xi+AkNLVjtPUJDTgUGzowwQ==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">ACC/AHA: Guideline on the assessment of cardiovascular risk</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/128/16/e240.full&amp;token=00inXdwsnxmDElcuPW2z2LjblLtNuarJCrgTvRJecCYuMp5k/DUzR/16BFTGfKV3ohq3RsIKylaIsXbWBVKuvw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">ACC/AHA: Guideline on the management of heart failure</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437738.63853.7a&amp;token=+21+rkuHbgz+J91/0tWwH3oyVL0OMW+h5oGX74CSpIj/a8a4+j0Okj38pde/5tLvVJ8ftgZLkQgStmLFMmTf1S0YiYXyCxC55kUqGkNglGU=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">ACC/AHA: Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437739.71477.ee&amp;token=TSJXpuRO4jxiFVWoZWeB34CVGLYDq3XdwNZTf6rNkhaVz5dd/cqAN2VjMH/MtdqrsOw71CECecISB+1sfv/2TWgpuv1YRXA/mvi/HRydc7k=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">ACC/AHA/The Obesity Society (TOS): Guideline on the management of overweight and obesity in adults</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/amda-lipid-lowering-medications/&amp;token=0oc+KlzcHVCj+ivgtzN0ScC0kHtxb22abTHaCFiLIefvJprRX+j+wbSG06OXMhh9OpTVJgx40abAYp60QxbUE56N1mY2BGCg0bfMwSbhXiM=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Choosing Wisely: Don't routinely prescribe lipid-lowering medications in individuals with a limited life expectancy</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://pdfs.semanticscholar.org/46c4/e41e301fd7acee8bb19248e92bd9f426b08f.pdf&amp;token=pPznrwrfN/NvD6tl9VfFnFbY32bshyHCpkZkgh6xshSpn9gqJ/ygCc9yF8ikN7/dwr/Ar1CUqyiimF1FCJElSup1yOxcCkkwFLwgkAVYZLM=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">NLA: Consensus statement on obesity, adiposity, and dyslipidemia</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.aafp.org/afp/2011/0901/p551.pdf&amp;token=Zhk3SsDNzGEOSDTcBVv9fTso+SLwEIlvi1Mt+M/TxjHfchCbXEZdfI9ucbnxMEK+rwC1JCwUsNIWoeWxLU0oqw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">American Academy of Family Physicians (AAFP): Pharmacologic treatment of hyperlipidemia</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/124/23/e652&amp;token=00inXdwsnxmDElcuPW2z2LjblLtNuarJCrgTvRJecCbKjEDa3RSa4Ud2dnYEJrS7cDRVlRm7g0eozrnCnEhd2w==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">American College of Cardiology Foundation (ACCF)/AHA: Guideline for coronary artery bypass graft surgery</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/123/11/1243&amp;token=00inXdwsnxmDElcuPW2z2LjblLtNuarJCrgTvRJecCYF8BnoWtS6A+oLKoFsqkNgypfUQ+Y26pSxqACNIUchWw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">AHA: Effectiveness-based guidelines for the prevention of cardiovascular disease in women, update</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/circulationaha/123/20/2292.full.pdf&amp;token=KnLSUdPZT2+I6zHTLSHg4hkC6JwlP/NLa/j69p5xLsjntg8EtWf3z3ddQtZaqeVwHZi96tAlqufo/3VxdGioRC+aE87GRLqDEeodmrqT0jc=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">AHA: Scientific statement on triglycerides and cardiovascular disease</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://circ.ahajournals.org/content/124/4/e54.long&amp;token=00inXdwsnxmDElcuPW2z2LjblLtNuarJCrgTvRJecCZ0sH9Hjm5Z/Fv49jyEDyZJHBnyC5rfUeQ7MSIfNGE7cQ==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">ASA/ACCF/AHA/American Association of Neuroscience Nurses (AANN)/American Association of Neurological Surgeons (AANS)/American College of Radiology (ACR)/American Society of Neuroradiology (ASNR)/Congress of Neurological Surgeons (CNS)/Society of Atherosclerosis Imaging and Prevention (SAIP)/Society for Cardiovascular Angiography and Interventions (SCAI)/Society of Interventional Radiology (SIR)/Society of NeuroInterventional Surgery (SNIS)/Society for Vascular Medicine (SVM)/Society for Vascular Surgery (SVS): Guideline on the management of patients with extracranial carotid and vertebral artery disease</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.lipid.org/sites/default/files/articles/familial_hypercholesterolemia_1.pdf&amp;token=dbIr7oMJpgQ9wDmt4jcIFyYdERvjSG13MBtbdAEiZQp+cvWzh29JdQSVQ3/dKpACQRQhIhX07pgeJ4KljP7VhwwRjesYZloiWydXyDn3lVY=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">NLA: Clinical guidance on familial hypercholesterolemia &ndash; Screening, diagnosis and management of pediatric and adult patients</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://content.onlinejacc.org/article.aspx?articleid=1138812&_ga=1.19233784.1352707548.1476387702&amp;token=m716hAEibxtxwh/k+gBQUIMyfCZyilQq1kDYA1HziOWmgOS0UqXJHFmr6h3O247CsDBTz3x3qtfuzXtmC65TrjsIDK64xGmmmrH6zN7Rt4/36D07z3DpIyit3DibJpJU&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">American Diabetes Association (ADA) and ACC: Consensus conference report on lipoprotein management in patients with cardiometabolic risk</a> (2008)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.aafp.org/afp/2007/0501/p1365.pdf&amp;token=Zhk3SsDNzGEOSDTcBVv9fTvVyBlrF2J2YExAfncfHZdQTmnsCgoWFLgH9X8lKrCdGFBMHJgu58aIztbJymOYqQ==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">AAFP: Management of hypertriglyceridemia</a> (2007)</p><p/><p class=\"headingAnchor\" id=\"H2796167906\"><span class=\"h1\">Europe</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://c.ymcdn.com/sites/www.eas-society.org/resource/resmgr/Publications/eurheartj.ehw152.full.pdf&amp;token=DVNLayUrzXaRcQTuKcpEXLsiY+P1e6HNo6Gv8utw5XB0k0Onf7gP2dB+01OWQYveLCFSP+g37HzKDadlHaN6UbEjsbzwIpfLCWPDCGZxNy+9KWD5M71MTAedLZMdV1Nf&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">European Atherosclerosis Society (EAS)-European Federation of Clinical Chemistry and Laboratory Medicine (EFLM): Consensus statement on fasting is not routinely required for determination of a lipid profile &ndash; Clinical and laboratory implications including flagging at desirable concentration cut-points</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://academic.oup.com/eurheartj/article/37/39/2999/2414995/2016-ESC-EAS-Guidelines-for-the-Management-of&amp;token=Cyt6TOPrHyL1jv2ykWuMySiImvTRXxfQwb3J8o9RWdYgBsoYx65DxKtLwmK+mlxnFM+kg1/4+GeHzcMhJeeRdD6rOxcTdBk2zDa4di6Gw33osfgCnfAscbWwcl62HK6sq3eftdGshuMbKhUdKqHbLg==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">European Society of Cardiology (ESC)/EAS: Guidelines for the management of dyslipidaemias</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehu274&amp;token=gZIBxcdXXy8ZzrgZKdK99928T5qXplAGsORWf9q4VuNx+KY4v/imF/4IGhzLzEj80BX8t4i2ozeBDZv18JqfKojDWp8hwzhMIbwUFBn0ghU=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">EAS: Position paper on homozygous familial hypercholesterolaemia &ndash; New insights and guidance for clinicians to improve detection and clinical management</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/eurheartj/article/34/45/3478/435928&amp;token=i+IJbZ3566jvLjqylaYc8Kl2hE2P5Gw5292rgeNt3TG4IPL6bI8ZGV9+aTqVjA1Ixj2JZaQHKBJ7GKshz+S6Ji3tanBx9ntek/nMK2E6IcE=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">EAS: Consensus statement on familial hypercholesterolaemia is underdiagnosed and undertreated in the general population &ndash; Guidance for clinicians to prevent coronary heart disease</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.eas-society.org/?page=polygenic_consensus&amp;token=q+tFDlZ3+JRQXZSWNuOsHDcIpCCkJSUt89xBMREfc8gfGJuTn83/NDCzlmltDDRzDTq9pFnqp9EYIjQfyqi9vw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">EAS: Consensus statement on the polygenic nature of hypertriglyceridaemia &ndash; Implications for definition, diagnosis, and management</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehs092&amp;token=UcSmPwD6bovOQ8ozX+mpJ/rvsp4dfec92/4dqARSmh1d0kYMSI1TS/L5ljTW5A30LBvmgoV/F2E+dlYkoxIdFw2GdfjsDy3m7cBFPv36/9A=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">ESC and other societies on cardiovascular disease prevention in clinical practice: European guidelines on cardiovascular disease prevention in clinical practice</a> (2012)</p><p/><p class=\"headingAnchor\" id=\"H3704430285\"><span class=\"h1\">United Kingdom</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/cg71&amp;token=lblfowwGB6QwC91WNuiIf6SDS220EiNtWYYQS8Gn6dP1fGRXiRMsfpEar6BGWnBO&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">National Institute for Health and Care Excellence (NICE): Clinical guideline on familial hypercholesterolaemia &ndash; Identification and management</a> (2008, updated 2017)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/cg181&amp;token=lblfowwGB6QwC91WNuiIf6SDS220EiNtWYYQS8Gn6dOQUKAQmhpNjoL66pJiceRy&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">NICE: Clinical guideline on cardiovascular disease &ndash; Risk assessment and reduction, including lipid modification</a> (2014, updated 2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/ta393&amp;token=lblfowwGB6QwC91WNuiIf6SDS220EiNtWYYQS8Gn6dPk80bmJUCd9PzSSAz0Pn4C&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">NICE: Technology appraisal guidance on alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/ta394&amp;token=lblfowwGB6QwC91WNuiIf6SDS220EiNtWYYQS8Gn6dMplqX9Ny1eR+ov8GAIAFDE&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">NICE: Technology appraisal guidance on evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/ta385&amp;token=lblfowwGB6QwC91WNuiIf6SDS220EiNtWYYQS8Gn6dOkg96w0JhiqzyOMxR3Fs0D&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">NICE: Technology appraisal guidance on ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/qs41&amp;token=lblfowwGB6QwC91WNuiIf6SDS220EiNtWYYQS8Gn6dNuY0HaNQgY+XeUaohWM3eQ&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">NICE: Quality standard on familial hypercholesterolaemia</a> (2013)</p><p/><p class=\"headingAnchor\" id=\"H2285377278\"><span class=\"h1\">Australia</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.csanz.edu.au/wp-content/uploads/2014/12/Familial-Hypercholesterolaemia_2013-November.pdf&amp;token=7MRLrMcdCNWcMLeRbMpIC3DAR/NP49AaGSVTmrTDzddF7L1bwwhTzrIC10JpV9NNmwsE1DlzNIjlm+eY3QGHPEOkwVmH3riRjfF7QO4p5sL3dpQTDqDb3W/sJS8PbB+QFWCsTIPMBhY+g8C07JmKmw==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Cardiac Society of Australia and New Zealand (CSANZ): Guidelines for the diagnosis and management of familial hypercholesterolaemia</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.racgp.org.au/download/Documents/AFP/2012/December/201212kirke.pdf&amp;token=rFa3g4eWRECSpJiNm4dUHN71G0fElIjELrYtOuRRxFfZo4ynjreogs66KioXvnXxWY5viEnndpwO9I+H4+yuVjTKKbkWiDH5YPEKVxy6Z44=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Australian Family Physician (AFP): Detecting familial hypercholesterolaemia in general practice</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.mja.com.au/system/files/issues/181_06_200904/ful10382_fm.pdf&amp;token=9I3ydis0xVQZpl8obpJhJ07mHSIdV5QVNYNfpzMPfRooRtA3r6Vemg1xIxZkAO29z7APUPNqywbszbFPIHvhbjYobvyV3BhF5Nvzny24UuY=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Practical Implementation Taskforce for the Prevention of Cardiovascular Disease: Evidence-based clinical aid for the prevention of cardiovascular disease</a> (2004)</p><p/><p class=\"headingAnchor\" id=\"H753556584\"><span class=\"h1\">Japan</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.jstage.jst.go.jp/article/jat/19/12/19_14621/_pdf&amp;token=X8Wrk4eiYEEKIDpM+opRDsp6w/oYXAn/ibmV2M7nS19DxU9L7RQs+zPn4McQNO9tJLB4C3FNpNHHLeNak5/5Rq8AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Japan Atherosclerosis Society (JAS): Guidelines for the management of familial hypercholesterolemia</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.jstage.jst.go.jp/article/jat/15/2/15_E590/_pdf&amp;token=X8Wrk4eiYEEKIDpM+opRDsp6w/oYXAn/ibmV2M7nS19AY2HA5qwqiC5V+AgHHtvRs8M8C6LOuIv/zpNOf/PexQ==&amp;TOPIC_ID=109532\" target=\"_blank\" class=\"external\">Committee for Epidemiology and Clinical Management of Atherosclerosis: Primary hyperlipidemia</a> (2008)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 109532 Version 8.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H2667277866\" id=\"outline-link-H2667277866\">Introduction</a></li><li><a href=\"#H559281906\" id=\"outline-link-H559281906\">Canada</a></li><li><a href=\"#H3701421603\" id=\"outline-link-H3701421603\">United States</a></li><li><a href=\"#H2796167906\" id=\"outline-link-H2796167906\">Europe</a></li><li><a href=\"#H3704430285\" id=\"outline-link-H3704430285\">United Kingdom</a></li><li><a href=\"#H2285377278\" id=\"outline-link-H2285377278\">Australia</a></li><li><a href=\"#H753556584\" id=\"outline-link-H753556584\">Japan</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-lipid-disorders-and-atherosclerosis-in-children\" class=\"medical medical_society_guidelines\">Society guideline links: Lipid disorders and atherosclerosis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-obesity-in-adults\" class=\"medical medical_society_guidelines\">Society guideline links: Obesity in adults</a></li></ul></div></div>","javascript":null}